Lobbyradar DE (Hrsg.). (2026). Presentation of MIND Foundation and the planned DiMension 
study (Phase III) for psychedelic treatment of resistant depression. 
EU funding opportunities.
Links to European partnership Brain Health. Abgerufen am 31.07.2026 von https://lbrgst.puca.biz/treffen/11621